Skip to main content

. 1988 Nov 26;297(6660):1392–1394. doi: 10.1136/bmj.297.6660.1392

Maintenance treatment with H2 receptor antagonists in patients with peptic ulcer disease: reduces morbidity in a significant minority of patients.

K G Wormsley ¹

PMCID: PMC1835100 PMID: 2905897

1392

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Boyd E. J., Wilson J. A., Wormsley K. G. Safety of ranitidine maintenance treatment of duodenal ulcer. Scand J Gastroenterol. 1984 May;19(3):394–400. [PubMed] [Google Scholar]
Boyd E. J., Wilson J. A., Wormsley K. G. The fate of asymptomatic recurrences of duodenal ulcer. Scand J Gastroenterol. 1984 Sep;19(6):808–812. [PubMed] [Google Scholar]
Penston J., Wormsley K. G. Adverse reactions and interactions with H2-receptor antagonists. Med Toxicol. 1986 May-Jun;1(3):192–216. doi: 10.1007/BF03259837. [DOI] [PubMed] [Google Scholar]
Wade A. G., Rowley-Jones D. Long term management of duodenal ulcer in general practice: how best to use cimetidine? Br Med J (Clin Res Ed) 1988 Apr 2;296(6627):971–974. doi: 10.1136/bmj.296.6627.971. [DOI] [PMC free article] [PubMed] [Google Scholar]
Wormsley K. G. Aetiology of ulcers. Baillieres Clin Gastroenterol. 1988 Jul;2(3):555–571. doi: 10.1016/s0950-3528(88)80005-8. [DOI] [PubMed] [Google Scholar]
Wormsley K. G. Long-term treatment of duodenal ulcer. Postgrad Med J. 1988;64 (Suppl 1):47–53. [PubMed] [Google Scholar]

ACTIONS

RESOURCES